精准医疗——用“超级试验”验证基础科学。
Tailoring cancer therapy - validating basic science with the 'supertrial'.
出版信息
Mol Oncol. 2009 Dec;3(5-6):389-91. doi: 10.1016/j.molonc.2009.08.001.
Abstract
A paradigm shift in research culture is needed in order to set up the large ambitious trials needed to make personalised medicine a reality. Emma Wilkinson talks to the experts about the hurdles they face and what needs to change.
摘要
需要在研究文化方面进行范式转变，以开展大型雄心勃勃的试验，从而使个性化医疗成为现实。Emma Wilkinson 与专家探讨了他们面临的障碍以及需要改变的地方。
相似文献
1
Tailoring cancer therapy - validating basic science with the 'supertrial'.精准医疗——用“超级试验”验证基础科学。
Mol Oncol. 2009 Dec;3(5-6):389-91. doi: 10.1016/j.molonc.2009.08.001.
2
Biological markers: Tailoring treatment and trials to prognosis.生物标志物：根据预后调整治疗与试验
Nat Rev Clin Oncol. 2013 Aug;10(8):429-30. doi: 10.1038/nrclinonc.2013.97. Epub 2013 Jun 11.
3
Conducting economic evaluation based on basket clinical trial in the area of precision medicine.基于精准医学领域的篮子临床试验进行经济评估。
Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):169-171. doi: 10.1080/14737167.2021.1865158. Epub 2020 Dec 24.
4
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.在靶向癌症治疗时代，影像生物标志物如何为临床试验和临床实践提供信息。
JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667.
5
Network science in clinical trials: A patient-centered approach.临床试验中的网络科学：以患者为中心的方法。
Semin Cancer Biol. 2018 Oct;52(Pt 2):135-150. doi: 10.1016/j.semcancer.2017.12.006. Epub 2017 Dec 24.
6
Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.重新构想临床试验：癌症治疗中创新生物标志物试验设计的回顾。
Br Med Bull. 2015 Jun;114(1):17-27. doi: 10.1093/bmb/ldv011. Epub 2015 Apr 28.
7
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics.迈向临床精准医学：从生物标志物发现到新型治疗方法。
Trends Pharmacol Sci. 2017 Jan;38(1):25-40. doi: 10.1016/j.tips.2016.10.012. Epub 2016 Nov 18.
8
Advancing cancer drug development through precision medicine and innovative designs.通过精准医学和创新设计推进癌症药物研发。
J Biopharm Stat. 2018;28(2):229-244. doi: 10.1080/10543406.2017.1402784. Epub 2017 Nov 27.
9
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.美国国立癌症研究所针对新的国家临床试验网络的精准医学计划。
Am Soc Clin Oncol Educ Book. 2014:71-6. doi: 10.14694/EdBook_AM.2014.34.71.
10
Future Approaches to Precision Oncology-Based Clinical Trials.基于精准肿瘤学的临床试验的未来方法。
Cancer J. 2019 Jul/Aug;25(4):300-304. doi: 10.1097/PPO.0000000000000383.
本文引用的文献
1
Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe.将《斯德哥尔摩宣言》变为现实：为欧洲癌症研究打造世界级基础设施。
Mol Oncol. 2009 Feb;3(1):5-8. doi: 10.1016/j.molonc.2008.11.001. Epub 2008 Nov 17.
2
The MINDACT trial: the first prospective clinical validation of a genomic tool.MINDACT试验：基因组工具的首次前瞻性临床验证。
Mol Oncol. 2007 Dec;1(3):246-51. doi: 10.1016/j.molonc.2007.10.004. Epub 2007 Oct 22.
Zotero 插件